Being a biological scientist by training with graduate work in psychology, and having developed schizophrenia over fifty years ago at the age of thirteen, I was thrilled to see the article in the February 24, 2008 issue of The New York Times by Alex Berenson concerning the initial success of researchers in treating schizophrenia using compounds that moderate the concentrations and effects of the synaptic neural transmitter glutamate. Dr. Daryle D. Schoepp and his coworkers are to be commended....
Read more »Recently, the medication Abilify (aripiprazole) was approved by the FDA for the... Read more »
The approval by the FDA for the use of Risperdal in the treatment of schizophrenia and bipolar... Read more »
It is a testament to the strangeness of what happened to me that I was doing something not many... Read more »
... Ideally, your doctor will have experience with schizophrenia treatment, and be aware of the... Read more »
"I think the most important thing is to accept the disorder like any other medical disorder, that... Read more »
The U.S. Food and Drug Administration has approved Risperdal for the treatment of schizophrenia and bipolar disorder in children and teens. Risperdal... Read summary »
By Lucy Williams, Ivanhoe Health Correspondent ORLANDO, Fla. (Ivanhoe Newswire) -- Some patients undergoing treatment for mental illness gain so... Read summary »
The Food and Drug Administration (FDA) has approved extended-release Invega for the treatment of schizophrenia. The FDA made the decision after... Read summary »
Drugmaker AstraZeneca is seeking approval from the Food and Drug Administration for a once-daily formula of Seroquel. Seroquel is currently approved... Read summary »
A study suggests that immaturity in the areas of the brain that control memory and mood may lead to schizophrenia. In a study involving mice that... Read summary »